185 related articles for article (PubMed ID: 9111873)
1. Double-blind placebo controlled specific immunotherapy with mixed Cupressaceae taxodiaceae pollens in respiratory allergy to Cupressus sempervirens.
Ariano R; Panzani RC; Augeri G
Allergol Immunopathol (Madr); 1997; 25(1):23-9. PubMed ID: 9111873
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
Ariano R; Panzani RC; Mistrello G
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of oral immunotherapy in respiratory allergy to Parietaria judaica pollen. A double-blind study.
Ariano R; Panzani RC; Augeri G
J Investig Allergol Clin Immunol; 1998; 8(3):155-60. PubMed ID: 9684188
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of sublingual specific immunotherapy in Cupressaceae allergy using an extract of Cupressus arizonica. A double blind study.
Ariano R; Spadolini I; Panzani RC
Allergol Immunopathol (Madr); 2001; 29(6):238-44. PubMed ID: 11834182
[TBL] [Abstract][Full Text] [Related]
5. Cross-reactivity between the pollens of Cupressus sempervirens (common cypress) and of Cryptomeria japonica (Japanese cedar).
Panzani R; Yasueda H; Shimizu T; Shida T
Ann Allergy; 1986 Jul; 57(1):26-30. PubMed ID: 3729079
[TBL] [Abstract][Full Text] [Related]
6. New clinical data and therapeutic prospects in Cupressaceae pollen allergy.
Ariano R; Panzani RC; Saraga J
Allerg Immunol (Paris); 2000 Mar; 32(3):135-8. PubMed ID: 10815250
[TBL] [Abstract][Full Text] [Related]
7. [Allergy to cypress pollen: preparation of a reference and standardization extract in vivo].
Leduc V; Charpin D; Aparicio C; Veber C; Guérin L
Allerg Immunol (Paris); 2000 Mar; 32(3):101-3. PubMed ID: 10815236
[TBL] [Abstract][Full Text] [Related]
8. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
Panzner P; Petrás M; Sýkora T; Lesná I
Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
[TBL] [Abstract][Full Text] [Related]
9. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study.
Hordijk GJ; Antvelink JB; Luwema RA
Allergol Immunopathol (Madr); 1998; 26(5):234-40. PubMed ID: 9885731
[TBL] [Abstract][Full Text] [Related]
10. An epidemiological survey of Cupressaceae pollenosis in Italy.
Italian Association of Aerobiology
J Investig Allergol Clin Immunol; 2002; 12(4):287-92. PubMed ID: 12940232
[TBL] [Abstract][Full Text] [Related]
11. Food allergy to apple and specific immunotherapy with birch pollen.
Hansen KS; Khinchi MS; Skov PS; Bindslev-Jensen C; Poulsen LK; Malling HJ
Mol Nutr Food Res; 2004 Nov; 48(6):441-8. PubMed ID: 15508179
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of specific IgG4 antibodies in respiratory allergy due to the pollen of Parietaria judaica. Evidence for a protective role.
Panzani RC; Ariano R; Augeri G
Allergol Immunopathol (Madr); 1996; 24(6):263-8. PubMed ID: 9010562
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
Frew AJ; Powell RJ; Corrigan CJ; Durham SR;
J Allergy Clin Immunol; 2006 Feb; 117(2):319-25. PubMed ID: 16461133
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study.
Mirone C; Albert F; Tosi A; Mocchetti F; Mosca S; Giorgino M; Pecora S; Parmiani S; Ortolani C
Clin Exp Allergy; 2004 Sep; 34(9):1408-14. PubMed ID: 15347374
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of specific immunotherapy to cat dander: a double-blind placebo-controlled trial.
Varney VA; Edwards J; Tabbah K; Brewster H; Mavroleon G; Frew AJ
Clin Exp Allergy; 1997 Aug; 27(8):860-7. PubMed ID: 9291281
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of specific immunotherapy to mosquito bites.
Ariano R; Panzani RC
Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):131-8. PubMed ID: 15180354
[TBL] [Abstract][Full Text] [Related]
17. Monoid sublingual immunotherapy.
Palma-Carlos AG; Santos AS; Branco-Ferreira M; Pregal AL; Palma-Carlos ML
Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693
[TBL] [Abstract][Full Text] [Related]
18. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study].
Silny W; Czarnecka-Operacz M
Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298
[TBL] [Abstract][Full Text] [Related]
19. Effects of sublingual immunotherapy in patients sensitised to Ambrosia. An open controlled study.
Valle C; Bazzi S; Berra D; Sillano V; Puccinelli P; Parmiani S
Allergol Immunopathol (Madr); 2000; 28(6):311-7. PubMed ID: 11269898
[TBL] [Abstract][Full Text] [Related]
20. Local conjunctival immunotherapy: the effect of dermatophagoides pteronyssinus local conjunctival immunotherapy on conjunctival provocation test in patients with allergic conjunctivitis.
Núñez JA; Cuesta U
Allergol Immunopathol (Madr); 2000; 28(6):301-6. PubMed ID: 11269896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
